Literature DB >> 7016719

On the significance of C2, C4, and factor B polymorphisms in disease.

C Rittner, J Bertrams.   

Abstract

In this review article, recent evidence is presented that some diseases like insulin-dependent diabetes mellitus, multiple sclerosis, and idiopathic membranous nephropathy, which are primarily associated with HLA-D,DR, are also related to the rare C2, C4, and Factor B alleles. Circumstantial evidence is available that at least some of these rare variants may be functionally deficient. Based on the concept of functionally interacting gene clusters, mutant complement genes may lead to impaired effector mechanisms in virus neutralization or lysis of virus-infected cells. Other mechanisms such as alteration of vascular permeability may be involved in the development of proliferative retinopathy and familial hypertension. In lepromatous lepra, an impaired cell-mediated lysis of M. leprae may be related to the hemolytically inactive C4F1 allelic product.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016719     DOI: 10.1007/bf00274674

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  58 in total

1.  Linkage relationship of C2 deficiency, HLA and glyoxalase I loci.

Authors:  M L Mahowald; A P Dalmasso; R A Petzel; E J Yunis
Journal:  Vox Sang       Date:  1979       Impact factor: 2.144

2.  Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex.

Authors:  H D Ochs; S I Rosenfeld; E D Thomas; E R Giblett; C A Alper; B Dupont; J G Schaller; B C Gilliland; J A Hansen; R J Wedgwood
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

3.  Gene clusters and the HLA system.

Authors:  W F Bodmer
Journal:  Ciba Found Symp       Date:  1979 Jun 27-29

4.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Linkage of HL-A and GBG.

Authors:  F H Allen
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

6.  Serum concentration and functional efficiency of factor B alleles.

Authors:  G Mauff; R Adam; B Wachauf; H W Hitzeroth; C Hiller
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

7.  A hemolytically inactive gene product of factor B.

Authors:  G Mauff; G Federmann; G Hauptmann
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

8.  A haemolytically non-active C4 gene product.

Authors:  P Teisberg; B Olaisen; R Nordhagen; E Thorsby; T Geddedahl
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

9.  HLA-A, B, C, DR, Bf, and C2 alleles in insulin-dependent diabetes mellitus with proliferative retinopathy.

Authors:  J Bertrams; G Dewald; M Spitznas; C Rittner
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

10.  Properdin factor B-polymorphism. An indication for the existence of a Bf O-allele.

Authors:  S Weidinger; F Schwarzfischer; H Cleve
Journal:  Z Rechtsmed       Date:  1979-08
View more
  17 in total

1.  A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B (a marker for type 1 diabetes).

Authors:  S Simon; Z Awdeh; R D Campbell; P Ronco; S J Brink; G S Eisenbarth; E J Yunis; C A Alper
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis.

Authors:  H Nakagawa; S Akazaki; A Asahina; K Tokunaga; K Matsuki; S Kuwata; Y Ishibashi; T Juji
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  DNA polymorphism of the C2 locus.

Authors:  D R Bentley; R D Campbell; S J Cross
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 4.  Application of molecular cloning to studies on the complement system.

Authors:  K B Reid
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

5.  Contrasting evolutionary histories among tightly linked HLA loci.

Authors:  W Klitz; G Thomson; M P Baur
Journal:  Am J Hum Genet       Date:  1986-09       Impact factor: 11.025

6.  Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.

Authors:  K Tokunaga; K Omoto; T Juji; T Itoh
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles.

Authors:  S J Cross; J H Edwards; D R Bentley; R D Campbell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 8.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

9.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

Authors:  J McCluskey; V J McCann; P H Kay; P J Zilko; F T Christiansen; G J O'Neill; R L Dawkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

10.  The complement component C4 in black Americans with type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Budowle; J M Roseman; R C Go; B O Barger; R T Acton
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.